← Alle mensen

GA

Gregory A Otterson

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab plus ipilimumab als eerstelijns bij NSCLC: CheckMate 227 vierjaars

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022-02

Pembrolizumab plus ipilimumab of placebo bij PD-L1≥50% NSCLC: KEYNOTE-598 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juli 2021

Nivolumab plus ipilimumab versus chemotherapie bij PD-L1≥1% NSCLC: CheckMate 227 vierjaars

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-04

Nivolumab plus ipilimumab bij NSCLC met hoge tumormutationele last: CheckMate 227

The New England journal of medicine · 31 mei 2018